| A Bioequivalence Study Between Two Casdatifan Tablet Strengths and Food Effect Study of Casdatifan in Healthy Adult Participants (NCT07641881) | Arcus Biosciences, Inc. | 2026-05-29 |
| Comparative Evaluation of Nicotine Analogs (NCT07585006) | Ohio State University Comprehensive Cancer Center | 2026-05-29 |
| Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin (NCT07634770) | Sam Chun Dang Pharm. Co. Ltd. | 2026-05-29 |
| Adebrelimab Combined With SHR2554 in Relapsed/Refractory PTCL and NK/T-Cell Lymphoma (NCT07615283) | Sun Yat-sen University | 2026-05-29 |
| Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies (NCT07444632) | M.D. Anderson Cancer Center | 2026-05-28 |
| A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) (NCT07633197) | Changchun BCHT Biotechnology Co. | 2026-05-28 |
| Open-label Study of SKY-GJB2 in Pediatric Subjects With GJB2-mediated Hearing Loss (NCT07627971) | Skylark Bio Inc. | 2026-05-28 |
| A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 ) (NCT07101328) | Eli Lilly and Company | 2026-05-28 |
| A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA) (NCT07607964) | AbbVie | 2026-05-28 |
| Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer (NCT07604571) | Novartis Pharmaceuticals | 2026-05-28 |
| Amivantamab Combined With Intrathecal Pemetrexed for LM From EGFR-Mutated Lung Adenocarcinoma (NCT07744529) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-05-28 |
| Drug-Drug Interaction Study of Atumelnant in Healthy Participants (NCT07570082) | Crinetics Pharmaceuticals Inc. | 2026-05-28 |
| A Phase 1 Study of the Safety and Tolerability of CTX-10726 (NCT07419841) | Compass Therapeutics | 2026-05-28 |
| Dapagliflozin to Reduce the Decline in Renal Function in Patients Newly Diagnosed With Lupus Nephritis (NCT07678203) | Hospital Civil Juan I. Menchaca | 2026-05-28 |
| Phase 1/1b Trial Of Olutasidenib And Ziftomenib For NPM1 And IDH1 Co-Mutated Acute Myeloid Leukemia (NCT07411586) | M.D. Anderson Cancer Center | 2026-05-28 |
| A Dose Escalation Phase 1 Study of HXN5003 in Healthy Participants (NCT07549750) | Helixon Biotechnology (Suzhou) Co., Ltd | 2026-05-27 |
| Treatment of Antibody-Mediated Rejection (ABMR) With CarBel (NCT06918990) | National Institute of Allergy and Infectious Diseases (NIAID) | 2026-05-27 |
| A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer (NCT07619339) | Memorial Sloan Kettering Cancer Center | 2026-05-27 |
| Safety and Efficacy of PTH-IA (NCT07541209) | National Institute of Dental and Craniofacial Research (NIDCR) | 2026-05-27 |
| Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors (NCT07512583) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2026-05-27 |
| A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma (NCT07477587) | Shanghai Henlius Biotech | 2026-05-27 |
| A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment (NCT07559474) | Incyte Corporation | 2026-05-27 |
| Drug-drug Interaction Study of ZT002 Injection in Overweight and Obese Participants (NCT07550816) | Beijing QL Biopharmaceutical Co.,Ltd | 2026-05-27 |
| A Phase I Study to Evaluate the Safety and Dosimetry of Imaging With 68Ga-OncoACP3 in Prostate Cancer (NCT07600554) | Philogen S.p.A. | 2026-05-27 |
| The Pharmacokinetics of a Hemp-Based Topical Product (NCT07603518) | Johns Hopkins University | 2026-05-26 |
| A First-in-human Phase I Study to Evaluate EMB-15 in Patients With Locally Advanced or Metastatic Solid Tumors. (NCT07607054) | Shanghai EpimAb Biotherapeutics Co., Ltd. | 2026-05-26 |
| Exploration of Circular RNA in B-cell Hematologic Malignancies (NCT07774572) | Ruijin Hospital | 2026-05-26 |
| A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD) (NCT07513441) | H. Lundbeck A/S | 2026-05-26 |
| HL-300 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis (NCT07629778) | Hangzhou Highlightll Pharmaceutical Co., Ltd | 2026-05-26 |
| SAR447971 First-in-human Study (NCT07629336) | Sanofi | 2026-05-26 |
| IASO-782 in Systemic Lupus Erythematosus (NCT07483346) | Shanghai IASO Biotechnology Co., Ltd | 2026-05-26 |
| A Study to Evaluate the Pharmacokinetics of HRS9531 Injection in Participants With Mild, Moderate, and Normal Hepatic Function (NCT07540754) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2026-05-26 |
| A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults (NCT07536308) | National Institute of Allergy and Infectious Diseases (NIAID) | 2026-05-26 |
| A Study to Assess the Adverse Events and How Bretisilocin Intramuscular Injection Moves Through the Body of Healthy Adult Participants (NCT07604558) | AbbVie | 2026-05-26 |
| Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas (NCT07544992) | City of Hope Medical Center | 2026-05-26 |
| A Study to Evaluate JL18008 in Subject With HIV Immunological Non-Responders (NCT07579741) | Jecho Biopharmaceuticals Co., Ltd. | 2026-05-26 |
| Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With Asthma (NCT07665892) | Aspeya, Inc. | 2026-05-26 |
| TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer (NCT07377526) | M.D. Anderson Cancer Center | 2026-05-26 |
| A Phase I, Dose Escalation, Open-label, Multicenter Study of EA5 Injection in Adults With APS and Recurrent Thrombosis (NCT07632976) | Shanghai Lanyi Therapeutics Co., Ltd. | 2026-05-25 |
| Intratumoral N17350 in Advanced Solid Tumors (NCT07339176) | Onchilles Pharma Inc | 2026-05-25 |
| A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R08b in Parkinson's Disease Patients With GBA1 Mutations (NCT07414290) | Shanghai Vitalgen BioPharma Co., Ltd. | 2026-05-25 |
| HEART: Pilot Randomized Controlled Trial (NCT07483177) | Mayo Clinic | 2026-05-25 |
| A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer (NCT07570979) | Novartis Pharmaceuticals | 2026-05-25 |
| To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of LYNC-101 for Injection in Healthy Adult Participants (NCT07505030) | LyncBio Therapeutics Co., Ltd. | 2026-05-25 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of IBIO-600 in Overweight or Obese Adults (NCT07487376) | iBio, Inc. | 2026-05-24 |
| Clinical Trial of the 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid) (NCT07600983) | CanSino Biologics Inc. | 2026-05-24 |
| A Phase I Clinical Study of HLX316 in Participants With Advanced/Metastatic Solid Tumors (NCT07541534) | Shanghai Henlius Biotech | 2026-05-22 |
| Trial of HSK44459 Cream for the Management Plaque Psoriasis (NCT07623486) | Haisco Pharmaceutical Group Co., Ltd. | 2026-05-22 |
| Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors (NCT06914479) | University of Michigan Rogel Cancer Center | 2026-05-22 |
| First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis (NCT07527923) | Regeneron Pharmaceuticals | 2026-05-22 |
| A Clinical Trial in Healthy Participants to Study the Effect of a Single Dose of MK-8527 on Levels of Methadone (MK-8527-020) (NCT07528508) | Merck Sharp & Dohme LLC | 2026-05-22 |
| A Study to Test the Safety and Blood Levels of PMG1016 in Healthy Adults (NCT07615985) | Pulmongene Ltd. | 2026-05-22 |
| A Study of TRC003 in the Treatment of Patients With Progressive PSMA-positive mCRPC (NCT07567521) | C Ray Therapeutics | 2026-05-22 |
| MDMA Assisted Therapy for BN (NCT07542145) | Icahn School of Medicine at Mount Sinai | 2026-05-22 |
| Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML (NCT07508982) | M.D. Anderson Cancer Center | 2026-05-22 |
| Safety and Preliminary Activity of BI115 in Advanced SCLC (NCT07559019) | Innovent Biologics (Suzhou) Co. Ltd. | 2026-05-21 |
| Phase I Clinical Trial of Adsorbed Tetanus Vaccine (NCT07598890) | Aimei Vacin BioPharm (Zhejiang) Co., Ltd. | 2026-05-21 |
| A Phase 1 Study of IM-1617 in Participants With Advanced Cancer (NCT07578571) | Immunome, Inc. | 2026-05-21 |
| A Study of LY3439539 in Participants With Alzheimer's Disease (NCT07598370) | Eli Lilly and Company | 2026-05-21 |
| A Relative Bioavailability and Bioequivalence Study of Varegacestat in Healthy Participants (NCT07610005) | Immunome, Inc. | 2026-05-21 |
| The Role of the LC-NA System in Experimental Sleep Fragmentation (NCT07167316) | Hans-Peter Landolt | 2026-05-21 |
| A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis (NCT07250646) | Aspera Biomedicines, Inc. | 2026-05-21 |
| Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies (NCT07644039) | PharmaMar | 2026-05-21 |
| Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT (NCT04520139) | University of California, Irvine | 2026-05-21 |
| A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and Relapsed /Refractory Pediatric Acute Leukemia Patients (NCT07052994) | M.D. Anderson Cancer Center | 2026-05-21 |
| A Phase 1, First-in-human Study of VX-433 (NCT07584434) | Vertex Pharmaceuticals Incorporated | 2026-05-21 |
| Safety and Efficacy of FAP iCDC in Ischemic Cardiomyopathy (NCT07505199) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-05-21 |
| Novel Biomarkers of Non-IgE Immediate Hypersensitivity Drug Reactions (NCT07605806) | Johns Hopkins University | 2026-05-21 |
| ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome (NCT07531745) | Ionis Pharmaceuticals, Inc. | 2026-05-21 |
| Therapeutic RSK1 Targeting in Myelofibrosis (NCT07379125) | Washington University School of Medicine | 2026-05-20 |
| A Clinical Study of HRS-5765 in Healthy Participants (NCT07551167) | Chengdu Suncadia Medicine Co., Ltd. | 2026-05-20 |
| A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight (NCT07605052) | Novo Nordisk A/S | 2026-05-20 |
| A Study to Evaluate the Safety and Diagnostic Performance of F18 FBPA PET/CT Imaging in Solid Tumors (NCT07691775) | Heron Neutron Medical Corp. | 2026-05-20 |
| Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD) (NCT07559500) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2026-05-20 |
| Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status) (NCT06806228) | Petrov, Andrey | 2026-05-20 |
| A Study to Test How Different Doses of BI 3814916 Are Tolerated by Healthy People (NCT07486115) | Boehringer Ingelheim | 2026-05-20 |
| Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer (NCT07500298) | M.D. Anderson Cancer Center | 2026-05-20 |
| Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia (NCT07133997) | City of Hope Medical Center | 2026-05-20 |
| Phase 1b Ascending Dose Study of PanChol in Healthy Volunteers (NCT07107516) | Centre for Infectious Disease Research in Zambia | 2026-05-20 |
| Phase 1/2 Study of UI-102 in Selected Advanced Cancers (NCT07605962) | United Immunity, co., Ltd. | 2026-05-20 |
| To Evaluate the Impact of Smoking on PK After Single-dose Oral Administration of GS1-144 Tablets . (NCT07534176) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2026-05-20 |
| A Study of the Effects of Itraconazole on LY4395089 in Healthy Participants (NCT07592572) | Eli Lilly and Company | 2026-05-20 |
| A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) (NCT07306832) | AbbVie | 2026-05-20 |
| Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease (NCT07473323) | Mediar Therapeutics | 2026-05-19 |
| A Phase Ib/II Trial to Evaluate the Efficacy and Safety of HH-009 for the Treatment of FGF19-positive Advanced or Unresectable HCC (NCT07547553) | Huahui Health | 2026-05-19 |
| Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration (NCT07587515) | Eyconis INC. | 2026-05-19 |
| A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis (NCT07533955) | Jade Biosciences, Inc. | 2026-05-19 |
| A Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of KR23248 Capsules in Healthy Adult Subjects (NCT07585383) | Jiangxi Kvvit Pharmaceutical Co., Ltd. | 2026-05-19 |
| Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants Under Fasting Conditions (NCT07606105) | Sichuan Huiyu Pharmaceutical Co., Ltd | 2026-05-19 |
| A Study to Understand What the Body Does to the Study Medicine Called PF-07799544 When Taken by Healthy Adults (NCT07578636) | Pfizer | 2026-05-18 |
| A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or Obesity (NCT07597018) | Novo Nordisk A/S | 2026-05-18 |
| Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic Function (NCT07682818) | Zealand Pharma | 2026-05-18 |
| First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer (NCT07529717) | AstraZeneca | 2026-05-18 |
| A Phase I/II Study of JL19001 Injection Alone or in Combination With BCG in Subjects With High Risk Non-Muscle Invasive Bladder Cancer. (NCT07483970) | Jecho Biopharmaceuticals Co., Ltd. | 2026-05-18 |
| A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma (NCT07481357) | Dong-A ST Co., Ltd. | 2026-05-18 |
| Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder. (NCT07347405) | Francisco A Moreno | 2026-05-18 |
| huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma (NCT07343934) | University of Pennsylvania | 2026-05-18 |
| FMT for Pediatric SR-aGVHD (NCT07602751) | Bambino Gesù Hospital and Research Institute | 2026-05-18 |
| A Phase 1 Study of Single-Dose BW-50218 in Healthy Chinese Participants (NCT07577479) | Shanghai Argo Biopharmaceutical Co., Ltd. | 2026-05-18 |
| Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors (NCT07278479) | Molecular Partners AG | 2026-05-18 |